MYGENVIII

pharmaceutical products for the treatment of bleeding disorders; pharmaceutical products for the treatment of cardiovascular diseases; pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of diabetes; anti-infectives; pharmaceutical products for use in cell and gene therapy for the treatment of bleeding disorders, cardiovascular diseases, cancer, diabetes, and infections